Nutritional anemia

Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients

Retrieved on: 
Monday, November 28, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221127005020/en/
    CSL Vifor and Fresenius Kabi today announced that Chinas National Medical Products Administration (NMPA) has approved Ferinject, a preparation for intravenous iron therapy for the treatment of iron deficiency in adult patients for whom oral iron preparations are ineffective, oral iron preparations cannot be used or for whom there is a clinical need to deliver iron rapidly.
  • We are thrilled about the marketing authorization of Ferinject, which is a milestone for Chinese patients living with iron deficiency or iron deficiency anemia, said Herv Gisserot, General Manager of CSL Vifor.
  • There is a high unmet need in China, which has the worlds largest iron deficiency population, and we are confident that Ferinject can make a meaningful difference in the treatment of these patients.
  • This open label, randomized multicenter study showed that Ferinject is an effective and well-tolerated alternative to iron sucrose for the treatment of iron deficiency anemia that can provide an improved hemoglobin response and correction of iron deficiency in Chinese patients.

Blood Centers of America Recognizes Abbott with BCA President's Award

Retrieved on: 
Wednesday, April 27, 2022

WEST WARWICK, R.I., April 27, 2022 /PRNewswire/ --Citing exceptional support and partnership, Blood Centers of America (BCA) is recognizing Abbott with the BCA's President's Award at their April Board of Directors' Meeting.

Key Points: 
  • WEST WARWICK, R.I., April 27, 2022 /PRNewswire/ --Citing exceptional support and partnership, Blood Centers of America (BCA) is recognizing Abbott with the BCA's President's Award at their April Board of Directors' Meeting.
  • "Abbott understands that helping to address the challenges blood centers face every day will in turn help them fulfill their mission of making a lasting impact on the communities they serve" noted Bill Block, BCA President and CEO.
  • BCA and Abbott have partnered to identify innovative solutions to help address the challenges blood centers are facing in recruiting blood donors.
  • Blood Centers of America (BCA) represents independent community blood centers and is the largest blood supply network in the U.S.

Struggling With Hair Loss? Immunoprime Gets to the Root of the Issue

Retrieved on: 
Tuesday, April 26, 2022

Alopecia Areata is a largely unknown autoimmune disease that possibly is genetic or comes from exposure to viruses or chemicals.

Key Points: 
  • Alopecia Areata is a largely unknown autoimmune disease that possibly is genetic or comes from exposure to viruses or chemicals.
  • Androgenetic Alopecia can stem from pregnancy, menopause, hormone imbalance, and even something as simple as a nutritional deficiency.
  • The Inspira Nutritionals team decided to cut to the heart of the issue by developing its inaugural formula, Immunoprime.
  • This helps to eliminate many autoimmune symptoms, such as hair loss, by addressing the problem at its root, so to speak.

Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis

Retrieved on: 
Friday, November 26, 2021

Together, we are dedicated to support people at risk of and living with iron deficiency or iron deficiency anemia so they can lead better, healthier lives.

Key Points: 
  • Together, we are dedicated to support people at risk of and living with iron deficiency or iron deficiency anemia so they can lead better, healthier lives.
  • To learn more about the importance of early diagnosis and recognizing symptoms of iron deficiency, visit www.takeironseriously.com/raise-awareness .
  • Iron deficiency and iron deficiency anemia is estimated to affect one in three people worldwide7, yet despite the serious consequences and high prevalence8, it remains an under-recognized condition.
  • A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.

Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality

Retrieved on: 
Thursday, November 26, 2020

Iron Deficiency is a highly prevalent and potentially very serious condition that can have a significantly negative impact on health and wellbeing.

Key Points: 
  • Iron Deficiency is a highly prevalent and potentially very serious condition that can have a significantly negative impact on health and wellbeing.
  • We are proud to have a growing coalition of partners joining us in marking Iron Deficiency Day 2020.
  • Together we have a strong voice underlining iron deficiency and iron deficiency anemia as a major threat to health, particularly among women.
  • Iron deficiency and iron deficiency anemia is estimated to affect one in three people worldwide2, yet despite the serious consequences and high prevalence3, it remains an under-recognized condition.

The Worldwide Market for Anemia Treatment Drugs to 2026 - The Overall Competitive Scenario is Expected to Observe a Paradigm Shift Towards Gene Therapy & Monoclonal Antibody Therapies

Retrieved on: 
Thursday, April 25, 2019

The major types of anemia that are treated with drugs are Iron deficiency anemia, thalassemia, aplastic anemia, hemolytic anemia, sickle cell anemia, and pernicious anemia.

Key Points: 
  • The major types of anemia that are treated with drugs are Iron deficiency anemia, thalassemia, aplastic anemia, hemolytic anemia, sickle cell anemia, and pernicious anemia.
  • The anemia treatment drugs market comprises drugs such as vitamins & iron supplements, antibiotics, immunosuppressant, bone marrow stimulants, corticosteroids, gene therapy & iron chelating agents.
  • The overall competitive scenario is expected to observe a paradigm shift towards gene therapy & monoclonal antibody therapies.
  • Global Anemia Treatment Drugs Market, by Type of Anemia, 2016 - 2026 (US$ Mn)